Most of us have accepted the common cold as an inevitable, recurring annoyance that medical science has largely ignored. We stock up on vitamin C and keep our distance from sick coworkers, but there is still no actual clinical way to prevent an infection.
Stripe, alongside support from leaders at OpenAI and Anthropic, is now funding a nonprofit research initiative specifically designed to find ways to prevent respiratory infections. Rather than focusing on treating symptoms after they appear, the project aims to identify the biological mechanisms that allow these viruses to thrive in the first place.
Computational targets for viral prevention
Unlike traditional lab-based methods that rely on trial-and-error chemistry, this project uses machine learning to sift through vast datasets of protein structures. These AI models identify specific host proteins that respiratory viruses require to replicate within human cells by finding predictable patterns in viral evolution. By flagging these high-probability molecular targets, the researchers can pinpoint exactly which proteins to block to prevent a virus from taking hold.
Think of it like changing the locks on a door so the virus no longer has a key to enter your cells, rather than trying to fight the virus once it is already inside your house. For someone who frequently deals with respiratory issues, this shift from reactive treatment to proactive prevention is significant. We are finally using computational resources to resolve the 'minor' illnesses that have persisted simply because they were previously too complex to decode. The real question isn't whether we can stop these viruses, but how much of our health were we willing to sacrifice because we assumed nature couldn't be engineered.
Liked this one? The next lands at breakfast.
Every story in tomorrow's AI news, rebuilt in plain English — five minutes, sources linked, free forever.
By joining you agree to receive Article's daily newsletter — unsubscribe in one click. Privacy